| For: | Ribeiro TCR, de Paula Boechat Soares V, Campos Fabri J, de Aragão Ramos LE. Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2026; 18(1): 111534 [PMID: 41640956 DOI: 10.4254/wjh.v18.i1.111534] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i1/111534.htm |
| Number | Citing Articles |
| 1 |
Chao Tang, Huanhuan Song, Qian Zhu, Pengzhe Han, Mengqi Wang, Xuchen Zhao, Nannan Chen, Xueqin Liu, Congzhong Hu, Xiaolong Li, Xifeng Fu, Raymond T. Chung, Steven Liang, Zhijun Pei, Yanzhang Tian, Tuo Shao. A [68Ga]-labeled PDGFRβ-targeting peptide PET probe for assessing MASH-related fibrosis in diet-induced preclinical models and human liver specimens. Biochemical Pharmacology 2026; 252 doi: 10.1016/j.bcp.2026.118205
|
| 2 |
Mario Romeo, Fiammetta Di Nardo, Claudio Basile, Carmine Napolitano, Paolo Vaia, Luigi Di Puorto, Mattia Indipendente, Alessia De Gregorio, Marcello Dallio, Alessandro Federico. From FIB-4 to the Artificial Intelligence Era: The Evolution of Non-Invasive Tools (NITs) for Tailored Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Livers 2026; 6(4) doi: 10.3390/livers6040071
|